CF Industries' Moat Is Cheap Natural Gas, Not a Market Conquest

CF Industries (CF) is up 72% this year, and the stock sits near its 52-week high after a second quarter that produced $727 million of net earnings on ammonia sold at sharply higher prices. The pitch circulating with the rally is that the company is "crushing European rivals" with a structural moat. When I set that claim against the cash flows and the gas data, I'd push back on the framing. There is a real, durable moat here, but it is not the thing the rally is celebrating. The moat is a cheap gas bill. The rally is a supply shock. Confusing the two is how a good company becomes an expensive entry.

The moat is a gas bill

Natural gas is roughly 80% of the cost of making ammonia, the feedstock behind nearly all nitrogen fertilizer. So the single most important number for this business is how much the producer pays for gas. CF buys at Henry Hub in the United States, which was around $2.90 per million BTU in July. The European benchmark, Dutch TTF, was $19.20 the same week — a transatlantic spread of about $16. By the end of August TTF had pushed toward €70 a megawatt-hour, and the gap kept widening as the supply crisis compounded.

That gap is not a blip; it is structural. After Russia lost its pipeline-gas advantage in Europe, European ammonia makers have been running at an estimated 75% of normal capacity for years, and urea production costs there are now quoted at $400 to $500 a ton. CF's North American plants, fed on a few dollars of gas, sit at the bottom of the global cost curve. That is a legitimate, hard-to-replicate edge: a European competitor cannot close a $16-per-MM-Btu input gap by running a better plant.

So far I'd grant the headline. The cost advantage is real, and it is the part of the business that deserves a premium.

The earnings are a shock, not a conquest

Here is where I'd stop. The multiple looks cheap — under 10x trailing earnings, about 5.2x trailing EV/EBITDA, and roughly 9% free-cash-flow yield on a $20 billion market — but a low multiple means nothing if the earnings are a spike. And a large share of CF's current earnings is a spike.

The driver was the closure of the Strait of Hormuz after the late-February attack on Iran knocked out Gulf production, from a region that normally ships roughly a third of global urea and ammonia exports. Urea prices jumped from about $482 a ton at the end of February to roughly $720 by mid-March, a 50% move in five weeks. CF's first-half adjusted EBITDA came in at $2.18 billion — a run rate that annualizes to roughly $4.4 billion, well above the company's own "mid-cycle" EBITDA of about $2.9 billion for a normal year. That gap tells you how far the current results sit above the steady state. (First-half net earnings were also flattered by a one-time ~$170 million litigation settlement.)

The moat and the spike are different animals. The moat is a permanent cost position that protects CF through downturns. The spike is a geopolitical windfall that reverses when supply comes back. And the windfall is already partly reversing: urea has fallen to around $420 a ton by early August, a 40% pullback from the high, as the strait reopened in fits and starts. As of this writing the situation is genuinely contested — some shipping trackers report the waterway still effectively closed to war-risk insurance with transiting traffic at a small fraction of normal, while others count a modest flow of tankers. I cannot resolve that, and I would not pay a premium for something I cannot resolve either.

What a buyer near $133 is partly buying is that uncertain, deflating premium. That is the part of the "crushing" narrative that does not hold up.

Strip the spike; the cash flow stands on its own

Set the geopolitical windfall aside, and what is left still clears my bar for a durable business. The balance sheet is the anchor: about $736 million of net debt against $2.5 billion of cash, which means survival is not in question and the payout is not at risk. Operating cash flow is running near $3.0 billion a year and free cash flow around $1.8 billion, and the company just raised its quarterly dividend 20% to $0.60 a share in July. Against the closest listed reference, the integrated nutrient major Nutrien, CF screens cheap — roughly 5x trailing EV/EBITDA to Nutrien's about 8x — even while converting more cash.

And the moat has a forward leg. Low-carbon ammonia was already about 10% of first-half sales at a premium of more than $20 a ton, and the company broke ground in August on Blue Point One, a 1.4-million-ton low-carbon ammonia plant in Louisiana slated for 2029. That is not an edge you can copy overnight, and it points at the durable position extending rather than eroding.

So here is the honest version. The "structural moat" is real — it is cheap American gas, and it is the reason the cash flow is reliable and the balance sheet stays clean. But it is not "crushing European rivals," and it is not the reason the stock is up 72% this year. The value case is the durable cost position and the low multiple on steady-state cash flow, not the commodity rally you would be chasing near the high. The margin of safety sits in the gas bill and the balance sheet, not in the strait. The one question that matters going forward is simply whether nitrogen prices hold at these elevated structural levels or settle back toward CF's own mid-cycle once Gulf supply normalizes — and the price you pay today already leans hard on the former being true.